Bone metabolism markers and bone mass in healthy pubertal boys and girls

2002 ◽  
Vol 57 (1) ◽  
pp. 107-116 ◽  
Author(s):  
S. C. C. M. Van Coeverden ◽  
J. C. Netelenbos ◽  
C. M. De Ridder ◽  
J. C. Roos ◽  
C. Popp-Snijders ◽  
...  
Author(s):  
Donvina Vaitkeviciute ◽  
Evelin Lätt ◽  
Jarek Mäestu ◽  
Toivo Jürimäe ◽  
Meeli Saar ◽  
...  

AbstractWe aimed to examine the associations of adipocytokines and circulating bone metabolism markers with bone mineral parameters in early pubertal boys with different physical activity level.Eighty-six early pubertal boys were divided into active and non-active boys according to the accumulated moderate-to-vigorous physical activity (MVPA) level. Body composition and bone mineral parameters were assessed and testosterone, leptin, adiponectin, osteocalcin (OC), and C-terminal telopeptide of type I collagen (CTX) were measured.Active subjects had significantly lower (p<0.05) body mass, body mass index (BMI), fat mass (FM), leptin, and sedentary time values, while non-active subjects had lower (p<0.05) vigorous physical activity level and femoral neck bone mineral density (FN-BMD). OC contributed to the models in physically active group and explained 6.6% and 9.7% of variance in whole body (WB) [F(5,44)=10.847; p<0.001] and lumbar spine bone mineral content (LS-BMC) [F(5,44)=4.158; p=0.004], respectively. No other biochemical parameters were found to be related to bone mineral parameters in either the active or non-active group.Bone metabolism markers were positively correlated with bone mineral values only in active pubertal boys. Leptin and adiponectin were not related to bone mineral parameters in active and non-active pubertal boys.


2022 ◽  
Vol 2022 ◽  
pp. 1-9
Author(s):  
Shuang Han ◽  
Fang Gong ◽  
Yifeng Xue ◽  
Chunxin Wang ◽  
Xiaowei Qi

Serum P1NP, one of the important biomarkers for bone turnover, is commonly used for the prediction of bone fracture and the prognosis of osteoporosis after therapy. We developed a P1NP chemiluminescence assay and evaluated changes in bone metabolism markers in lung transplant patients. The screened 2 P1NP antibodies with constructed antigens and α-1 chain antigens expressed by the Corynebacterium glutamate expression system were applied into assay development. The assay performance was evaluated to examine the reliability. A normal Q-Q plot was used to establish male reference interval. Changes of bone metabolism markers before and after lung transplantation in 19 patients were evaluated. The linear factor R of P1NP reagent was greater than 0.99. The limit of detection was 3.32 ng/ml. The precision of the three batches of P1NP reagents was lower than 8%. Method comparison with Roche P1NP reagent showed that the correlation coefficient R2 was 0.91. In the monitoring of bone mass in a short time, bone metabolism markers can better indicate the change of bone mass, while the traditional bone mineral density detection is lagging behind the bone metabolism markers. P1NP and β-CrossLap to bone mass change in patients after lung transplantation, and P1NP and β-CrossLap are very good clinical markers for bone mass monitoring.


2018 ◽  
Vol 2 (2) ◽  
pp. 68-74
Author(s):  
Foong Kiew Ooi

Osteoporosis is a disease characterised by a loss of bone mass and the structure deterioration of bone tissue, resulting in bone fragility and fractures. This disease imposes major burden on the health economy and being recognised as one of the major public health problems worldwide. To date, many strategies have been developed with the aim of preventing bone loss and increasing bone mass, these include involvement in physical activity programmes and through appropriate nutritional intake. Honey contains mainly carbohydrates, vitamins and minerals such as calcium, phosphorus and magnesium, which are believed to be important for enhancing bone health. This article discusses the findings of several research studies on bone properties and blood bone metabolism markers in response to combined exercises and honey supplementation in animals and humans, which have been carried out by the bone and exercise research team of Universiti Sains Malaysia.


2006 ◽  
Vol 64 (6) ◽  
pp. 625-631 ◽  
Author(s):  
L. Terpstra ◽  
D. L. Knol ◽  
S. C. Van Coeverden ◽  
H. A. Delemarre-van de Waal

2006 ◽  
Vol 9 (3) ◽  
pp. 11-13
Author(s):  
T G Vasil'eva ◽  
O G Maksimova ◽  
E A Kochetkova

We investigated 130 healthy children and adolescences, its dates of dual-energy X-ray absorbtiometry, bone metabolism markers. The formation of bone mass peak, bone's mineralization in healthy children is depending on age, anthropometric status, sex, dietary with uneven activity in the different local of skeleton. The level of bone metabolism markers is depending on period of life, with maximal dates in patient's 12-14 yeas old. The level of osteopenic syndrome in healthy children consist 15,39%.


2010 ◽  
Vol 74 (5) ◽  
pp. 339-350 ◽  
Author(s):  
L. Gracia-Marco ◽  
G. Vicente-Rodríguez ◽  
J. Valtueña ◽  
J.P. Rey-López ◽  
A.E. Díaz Martínez ◽  
...  

Author(s):  
Linda Denise Fernandes Moreira ◽  
Fernanda Cerveira A. O. Fronza ◽  
Rodrigo Nolasco dos Santos ◽  
Patrícia Lins Zach ◽  
Ilda S. Kunii ◽  
...  

Cells ◽  
2021 ◽  
Vol 10 (8) ◽  
pp. 1895
Author(s):  
Francesca Marini ◽  
Francesca Giusti ◽  
Federica Cioppi ◽  
Davide Maraghelli ◽  
Tiziana Cavalli ◽  
...  

Primary hyperparathyroidism (PHPT) is the most common endocrinopathy in multiple endocrine neoplasia type 1 (MEN1). Persistent levels of increased parathyroid hormone (PTH) result in a higher incidence of osteopenia and osteoporosis compared to the general population. Surgical removal of hyper-functioning parathyroid tissue is the therapy of choice. This retrospective study evaluated the effect of parathyroidectomy (PTX) on bone metabolism and bone mass in two series of patients with MEN1 PHPT and sporadic PHPT (sPHPT) by comparing bone metabolism-related biochemical markers and bone mineral density (BMD) before and after surgery. Our data confirmed, in a higher number of cases than in previously published studies, the efficacy of PTX, not only to rapidly restore normal levels of PTH and calcium, but also to normalize biochemical parameters of bone resorption and bone formation, and to improve spine and femur bone mass, in both MEN1 PHPT and sPHPT. Evaluation of single-patient BMD changes after surgery indicates an individual variable bone mass improvement in a great majority of MEN1 PHPT patients. In MEN1 patients, PTX is strongly suggested in the presence of increased PTH and hypercalcemia to prevent/reduce the early-onset bone mass loss and grant, in young patients, the achievement of the bone mass peak; routine monitoring of bone metabolism and bone mass should start from adolescence. Therapy with anti-fracture drugs is indicated in MEN1 patients with BMD lower than the age-matched normal values.


2011 ◽  
Vol 44 (17-18) ◽  
pp. 1425-1428 ◽  
Author(s):  
Alvaro Osorio ◽  
Esperanza Ortega ◽  
Jesús M. Torres ◽  
Pilar Sanchez ◽  
Estrella Ruiz-Requena

Sign in / Sign up

Export Citation Format

Share Document